Publicacións (264) Publicacións de Rafael Coveñas Rodríguez

2023

  1. A Silver Bullet or a Toolkit to Treat AUD? The Contribution of NK-1R Antagonists

    Journal of Psychiatry & Mental Disorders, Vol. 8, Núm. 1, pp. 1065

  2. Anatomy of hypothalamic and diencephalic nuclei involved in seasonal fertility regulation in ewes

    Frontiers in Veterinary Science, Vol. 10

  3. Association of Neurokinin-1 Receptor Signaling Pathways with Cancer

    Current Medicinal Chemistry, Vol. 31

  4. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?

    Current Medicinal Chemistry, Vol. 30, Núm. 16, pp. 1798-1812

  5. Improved Radioimmunodetection of Carcinomas with a Re-injection of Monoclonal Antibodies after Formation of Anti-mouse Antibodies

    Current Pharmaceutical Design, Vol. 29, Núm. 18, pp. 1409-1413

  6. Involvement of the Adrenocorticotropic Hormone in Cancer and Other Pathologies

    Advances in Health and Disease. (NOVA), pp. 185-208

  7. Involvement of the Opioid Peptide Family in Cancer Progression

    Biomedicines, Vol. 11, Núm. 7

  8. Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives

    Applied Sciences (Switzerland), Vol. 13, Núm. 13

  9. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  10. Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  11. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families

    Cancers, Vol. 15, Núm. 6

  12. Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer?

    Cancers

  13. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant

    International Journal of Molecular Sciences, Vol. 24, Núm. 21